Locations:
April 4, 2024/Innovations

Floreo Acquires Autism Eyes, a Cleveland Clinic Innovations Owned Autism Diagnostics and Assessment Company

Discover how Floreo's acquisition of Autism Eyes enhances autism therapy through VR and eye-tracking technology, supported by Cleveland Clinic Innovations' commitment to healthcare innovation.

A patient looks at a woman in a monitor while a doctor in a white lab coat watches.

At Cleveland Clinic Innovations, we are committed to advancing healthcare through strategic partnerships and innovative solutions. We are excited to share insights into a significant development in autism therapy technology. Floreo, a pioneering behavioral therapy virtual reality (VR) company specializing in diagnostics and assessment space for individuals with autism, has recently announced its acquisition of Autism Eyes, a Cleveland Clinic Innovations-owned autism diagnostics and assessment company. As part of the transaction, a representative of Cleveland Clinic will also join Floreo’s board of directors as an observer.

Floreo’s approach leverages immersive experiences to teach essential life skills and social behaviors in a safe and controlled environment for those with autism. This acquisition of Autism Eyes represents a strategic expansion of Floreo's capabilities, enhancing their ability to innovate and deliver even more impactful therapies. The existing diagnostic procedures are subjective and time-consuming, leading to substantial delays for patients.

"The rising incidence of autism demands cutting-edge technology solutions to help individuals and their families, and Cleveland Clinic remains committed to driving innovations in autism treatment and services," said Geoff Vince, PhD, Executive Director, Cleveland Clinic Innovations. "Floreo’s VR platform combined with the eye-tracking diagnostic capabilities of Autism Eyes will help build an integrated pathway tailored to each individual’s needs."

Autism Eyes brings valuable expertise and technology to Floreo's portfolio. Their platform, which utilizes eye-tracking technology to monitor and analyze user engagement and response during VR sessions, complements Floreo's existing offerings. This integration is expected to enhance the personalization and effectiveness of therapy sessions, providing clinicians with deeper insights into patient progress and needs.

This collaboration underscores the power of innovation and collaboration in driving meaningful advancements in healthcare. As partners in this journey, Cleveland Clinic Innovations continues to champion breakthrough technologies that make a difference.

Read the full press release on Floreo.

Latest from the Newsroom

UFC, Cleveland Clinic logos

UFC®, Cleveland Clinic Renew Longstanding Partnership

Panelists at Cleveland Clinic's London Innovation Summit

Cleveland Clinic Holds Second Annual London Innovation Summit

Exterior view of Cleveland Clinic's Main Campus

Newsweek Ranks Cleveland Clinic One of World’s Top Hospitals for Specialized Care

Rami Hazzi, M.D.

Rami Hazzi, M.D., Named New Leader of Cleveland Clinic Euclid Hospital

Vizient badge

Six Cleveland Clinic Hospitals Recognized as Top Performers by Vizient

Exterior view of Carson Valley Health

Carson Valley Health Becomes Cleveland Clinic Connected Member

Newborn baby in the hospital

Cleveland Clinic Children’s Expands Newborn Screening to Identify Virus that Can Lead to Hearing Loss and Developmental Delays

Map of Bermuda

Cleveland Clinic’s World-Class Care Now Available to More Bermuda Residents